Public Reporting

ACO Name and Location:

St. Rose Quality Care Network, LLC
3001 St. Rose Parkway
Henderson, NV 89052

ACO Primary Contact:

Primary Contact Name	Margie Roper
Primary Contact Phone Number	(702) 616-5719
Primary Contact Email Address	Margie.Roper@DignityHealth.org

Organizational Information:

ACO Participants

ACO Participants	ACO Participant in Joint Venture
Ensign Family Medicine Llc	N
Scott Selco, Professional Corporation	N
Dara J. Welborn, M.D., P.C.	N
S and S Kim Group, PC	N
Brian E. Lee, M.D., LTD	N
Sports Medicine Rehabilitation Associates	N
Dignity Health Medical Group Nevada, LLC	N
Armour, Christensen, Simon, Chtd	N
Siena Hills Primary Care, Llc	N
Kochy M. Y. Tang, D.O., A Professional Corporation	N
Rita B. Chuang MD LLC	N

ACO Governing Body:

Member
Last Name	First Name	Title / Position	Member’s Voting Power	Membership Type	ACO Participant TIN Legal Business Name/DBA, if Applicable
Simon	Irwin	Chair	1	ACO Participant Representative	Armour, Christensen, Simon, Chartered
Welborn	Dara	Payer Committee Chair	1	ACO Participant Representative	Dara J. Welborn, M.D., P.C.
Selco	Scott	Finance Committee Chair	1	ACO Participant Representative	Scott Selco, Professional Corporation
Flaviano	Casiano		1	ACO Participant Representative	Sports Medicine Rehabilitation Associates, A Flaviano Professional Corporation
Harouni	Rama		1	ACO Participant Representative	Dignity Health Medical Group Nevada, LLC
Pretzlaff	Robert	Hospital Representative: Chief Physician Executive	1	Community Stakeholder Representative	N/A
Bower	Joel		1	Medicare Beneficiary Representative	N/A
Bertoli	Troy		1	ACO Participant Representative	Dignity Health Medical Group Nevada, LLC
Venkat	Raji		1	ACO Participant Representative	Dignity Health Medical Group Nevada, LLC
Lee	Brian		1	ACO Participant Representative	Brian E. Lee, M.D., LTD
Salcedo	Anna	Secretary	1	ACO Participant Representative	Dara J. Welborn, M.D., P.C.
Ammar	Tarek		1	Community Stakeholder Representative	N/A

Key ACO Clinical and Administrative Leadership:

Margie Roper	ACO Executive
Teresa Hong	Medical Director
Dawnese Kindelt	Compliance Official
Robert Pretzlaff	Quality Assurance/Improvement Officer

Associated Committees and Committee leadership:

Committee Name	Committee Leader Name and Position
Payer Committee	Dr. Dara Welborn, Chair
Finance Committee	Dr. Scott Selco, Chair
Quality Committee	Vacant, Chair
Performance Evaluation Committee	Dr. Anna Salcedo, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

ACO professionals in a group practice arrangement
Network of individual practices of ACO professionals
Partnership or joint venture arrangement between hospitals and ACO professionals

Shared Savings and Losses:

Amount of Shared Savings/Losses

Shared Savings Distribution

Quality Performance Results:

2016 Quality Performance Results

ACO#	Measure Name	Rate	ACO Mean
ACO-1	CAHPS: Getting Timely Care, Appointments, and Information	N/A	80.51
ACO-2	CAHPS: How Well Your Providers Communicate	N/A	93.01
ACO-3	CAHPS: Patients’ Rating of Provider	N/A	92.25
ACO-4	CAHPS: Access to Specialists	N/A	83.49
ACO-5	CAHPS: Health Promotion and Education	N/A	60.32
ACO-6	CAHPS: Shared Decision Making	N/A	75.40
ACO-7	CAHPS: Health Status/Functional Status	N/A	72.30
ACO-34	CAHPS: Stewardship of Patient Resources	N/A	26.97
ACO-8	Risk-Standardized, All Condition Readmission	N/A	14.70
ACO-35	Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)	N/A	18.17
ACO-36	All-Cause Unplanned Admissions for Patients with Diabetes	N/A	53.20
ACO-37	All-Cause Unplanned Admissions for Patients with Heart Failure	N/A	75.23
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	N/A	59.81
ACO-9	Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)	N/A	9.27
ACO-10	Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )	N/A	14.53
ACO-11	Percent of PCPs who Successfully Meet Meaningful Use Requirements	N/A	82.72
ACO-39	Documentation of Current Medications in the Medical Record	N/A	87.54
ACO-13	Falls: Screening for Future Fall Risk	N/A	64.04
ACO-14	Preventive Care and Screening: Influenza Immunization	N/A	68.32
ACO-15	Pneumonia Vaccination Status for Older Adults	N/A	69.21
ACO-16	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up	N/A	74.45
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	N/A	90.98
ACO-18	Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan	N/A	53.63
ACO-19	Colorectal Cancer Screening	N/A	61.52
ACO-20	Breast Cancer Screening	N/A	67.61
ACO-21	Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented	N/A	76.79
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	N/A	77.72
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	N/A	18.24
ACO-41	Diabetes: Eye Exam	N/A	44.94
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	N/A	70.69
ACO-30	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic	N/A	85.05
ACO-31	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)	N/A	88.67
ACO-33	Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)	N/A	79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Payment Rule Waivers:

No, our ACO does not use the SNF 3-Day Rule Waiver.